Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

MLA

Mukherjee, Pranab K., et al. “Topical Gentian Violet Compared with Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1-Infected Participants.” AIDS (London, England), vol. 31, no. 1, Jan. 2017, pp. 81–88. EBSCOhost, https://doi.org/10.1097/QAD.0000000000001286.

APA

Mukherjee, P. K., Chen, H., Patton, L. L., Evans, S., Lee, A., Kumwenda, J., Hakim, J., Masheto, G., Sawe, F., Pho, M. T., Freedberg, K. A., Shiboski, C. H., Ghannoum, M. A., & Salata, R. A. (2017). Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS (London, England), 31(1), 81–88. https://doi.org/10.1097/QAD.0000000000001286

Chicago

Mukherjee, Pranab K, Huichao Chen, Lauren L Patton, Scott Evans, Anthony Lee, Johnstone Kumwenda, James Hakim, et al. 2017. “Topical Gentian Violet Compared with Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1-Infected Participants.” AIDS (London, England) 31 (1): 81–88. doi:10.1097/QAD.0000000000001286.